Screening compound: InChI=1S/C18H26N2O2/c1-14(2)17(21)20-12-15-6-4-5-7-16(15)22-18(13-20)8-10-19(3)11-9-18/h4-7,14H,8-13H2,1-3H3

Screening compound: InChI=1S/C18H26N2O2/c1-14(2)17(21)20-12-15-6-4-5-7-16(15)22-18(13-20)8-10-19(3)11-9-18/h4-7,14H,8-13H2,1-3H3
Screening compound: InChI=1S/C18H26N2O2/c1-14(2)17(21)20-12-15-6-4-5-7-16(15)22-18(13-20)8-10-19(3)11-9-18/h4-7,14H,8-13H2,1-3H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C18H26N2O2/c1-14(2)17(21)20-12-15-6-4-5-7-16(15)22-18(13-20)8-10-19(3)11-9-18/h4-7,14H,8-13H2,1-3H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S530-0014

Molecular Formula

C18H26N2O2 (C18 H26 N2 O2)

Compound Name

4-isobutyryl-1'-methyl-4,5-dihydro-3{H}-spiro[1,4-benzoxazepine-2,4'-piperidine]

IUPAC name

2-methyl-1-{1'-methyl-45-dihydro-3H-spiro[14-benzoxazepine-24'-piperidin]-4-yl}propan-1-one

SMILES

CC(C)C(N1Cc(cccc2)c2OC2(CCN(C)CC2)C1)=O

InChI

InChI=1S/C18H26N2O2/c1-14(2)17(21)20-12-15-6-4-5-7-16(15)22-18(13-20)8-10-19(3)11-9-18/h4-7,14H,8-13H2,1-3H3

InChI Key

NUFRIOZXTIAVRH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29008407

InChI=1S/C18H26N2O2/c1-14(2)17(21)20-12-15-6-4-5-7-16(15)22-18(13-20)8-10-19(3)11-9-18/h4-7,14H,8-13H2,1-3H3 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with InChI=1S/C18H26N2O2/c1-14(2)17(21)20-12-15-6-4-5-7-16(15)22-18(13-20)8-10-19(3)11-9-18/h4-7,14H,8-13H2,1-3H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C18H26N2O2/c1-14(2)17(21)20-12-15-6-4-5-7-16(15)22-18(13-20)8-10-19(3)11-9-18/h4-7,14H,8-13H2,1-3H3?
Check Price and Availability of InChI=1S/C18H26N2O2/c1-14(2)17(21)20-12-15-6-4-5-7-16(15)22-18(13-20)8-10-19(3)11-9-18/h4-7,14H,8-13H2,1-3H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C18H26N2O2/c1-14(2)17(21)20-12-15-6-4-5-7-16(15)22-18(13-20)8-10-19(3)11-9-18/h4-7,14H,8-13H2,1-3H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C18H26N2O2/c1-14(2)17(21)20-12-15-6-4-5-7-16(15)22-18(13-20)8-10-19(3)11-9-18/h4-7,14H,8-13H2,1-3H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C18H26N2O2/c1-14(2)17(21)20-12-15-6-4-5-7-16(15)22-18(13-20)8-10-19(3)11-9-18/h4-7,14H,8-13H2,1-3H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C18H26N2O2/c1-14(2)17(21)20-12-15-6-4-5-7-16(15)22-18(13-20)8-10-19(3)11-9-18/h4-7,14H,8-13H2,1-3H3 available by request